John Stroh

John Stroh is the interim CEO at GATC Health. Previously, they were the managing director at Tellson Corporate Services, LLC from January 2016 to August 2020. In this role, they were responsible for leading the healthcare team and advising on strategic partnering and M&A transactions. John has also served as the president and CEO of Nanospectra Biosciences from April 2011 to March 2013, and as the chief executive officer of Venture Analysis Group from January 2015 to August 2020.

John Stroh graduated from the UCLA Anderson School of Management with a degree in business. John also holds a bachelor's degree in business, management, marketing, and related support services from California State University-Long Beach - College of Business Administration. John Stroh is also certified from Shearson Lehman Brothers in securities liscences.

Some individuals on their team include Eric Mathur - Chief Innovation Officer, Jayson Uffens - Chief Technology Officer & Cofounder, and Tyrone Lam - COO.